Semaglutide

5mg · Lyophilized Powder

Semaglutide is a GLP-1 receptor agonist peptide with an extended half-life of approximately 168 hours, enabling once-weekly subcutaneous administration. Studied extensively in Phase 3 trials, it modulates appetite signalling through the hypothalamus while slowing gastric emptying and improving postprandial glucose disposal. Research demonstrates dose-dependent reductions in body weight alongside improvements in cardiovascular risk markers at clinical doses up to 2.4 mg weekly. Its acylation chemistry enables high albumin binding for sustained systemic exposure.

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.